Foscan je indiciran za paliativno zdravljenje bolnikov z napredovalim ploščatoceličnim rakom glave in vratu, pri katerih prejšnja zdravljenja niso bila uspešna in niso primerni za radioterapijo, kirurški poseg ali sistemsko kemoterapijo.
Foscan is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.